Know about EU's Galileo rival, how cannabis component may fight psychosis

Britain said on Wednesday it would start work on an alternative satellite system to the European Union's Galileo project to ensure its national security if it is barred from equal access to the EU program after Brexit.

Britain starts work on satellite system to rival EU's Galileo

Britain said on Wednesday it would start work on an alternative satellite system to the European Union's Galileo project to ensure its national security if it is barred from equal access to the EU program after Brexit. The British government, which still wants to remain involved in Galileo, said it would spend 92 million pounds ($117 million) on plans for an independent satellite system, led by the UK Space Agency with support from the Ministry of Defense.

Today, we are committing £92m from our Brexit readiness fund to design a national alternative to the EU's Galileo satellite system. We have a world-leading space sector and will do what it takes to support the jobs and expertise the UK needs.https://t.co/BAeByaMo04

— Philip Hammond (@PhilipHammondUK) August 29, 2018

Scientists unpick how cannabis component may fight psychosis

British scientists have unraveled how a non-intoxicating component of cannabis acts in key brain areas to reduce abnormal activity in patients at risk of psychosis, suggesting the ingredient could become a novel anti-psychotic medicine. While regular use of potent forms of cannabis can increase the chances of developing psychosis, the chemical cannabidiol or CBD appears to have the opposite effect.

(With inputs from Reuters)